More on DSGN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.69 |
|
|||
| Open | $3.71 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.13 | ||||
| Day Low | $3.71 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 423,133 | ||||
- Form 4 Design Therapeutics, For: Mar 22 Filed by: Schmid John P.
- Form 4 Design Therapeutics, For: Mar 25 Filed by: Berger Heather A.
- Form 3 Design Therapeutics, For: Mar 13 Filed by: Kim Jae B.
- Design Therapeutics, Inc. (DSGN) Tops Q4 EPS by 10c
- Form S-8 Design Therapeutics,
- Form 10-K Design Therapeutics, For: Dec 31
- Form 8-K Design Therapeutics, For: Mar 19
- Design Therapeutics Inc. (DSGN) Outlines Progress Across GeneTAC Platform, Reports Q4
- Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
- Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
Entities mentioned with DSGN
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- IPO | View Related Stories »
- Goldman Sachs | View Related Stories »
- Jefferies & Co | View Related Stories »
- JMP Securities | View Related Stories »
- 13D | View Related Stories »
- Show More...
